Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Langley

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|October 17, 2013
Genotypic correlates of susceptibility to HIV-1 attachment inhibitor BMS-626529, the active agent of the prodrug BMS-663068Nannan Zhou, Beata Nowicka-Sans, Brian McAuliffe, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|July 29, 2011
Cloning, purification, crystallization and preliminary X-ray analysis of the catalytic domain of human receptor-like protein tyrosine phosphatase γ in three different crystal formsKevin Kish, Patricia A McDonnell, Valentina Goldfarb, et al.
Nature Structural & Molecular Biology|January 4, 2024
Co-opting the E3 ligase KLHDC2 for targeted protein degradation by small moleculesChristopher M Hickey, Katherine M Digianantonio, Kurt Zimmermann, et al.
Bioorganic & Medicinal Chemistry Letters|December 24, 2018
Uncialamycin as a novel payload for antibody drug conjugate (ADC) based targeted cancer therapyNaidu S Chowdari, Chin Pan, Chetana Rao, et al.
Bioorganic & Medicinal Chemistry|February 6, 2014
Structure activity relationship studies of 3-arylsulfonyl-pyrido[1,2-a]pyrimidin-4-imines as potent 5-HT₆ antagonistsShuanghua Hu, Yazhong Huang, Yong-Jin Wu, et al.
Molecular Pharmacology|June 25, 2017
A Functional Na<sub>V</sub>1.7-Na<sub>V</sub>Ab Chimera with a Reconstituted High-Affinity ProTx-II Binding SiteRamkumar Rajamani, Sophie Wu, Iyoncy Rodrigo, et al.
Journal of Medicinal Chemistry|March 14, 2014
Discovery and development of hepatitis C virus NS5A replication complex inhibitorsMakonen Belema, Omar D Lopez, John A Bender, et al.
Organic Letters|March 25, 2005
Novel 3',6'-anhydro and N12,N13-bridged glycosylated fluoroindolo[2,3-a]carbazoles as topoisomerase I inhibitors. Fluorine as a leaving group from sp3 carbonMark G Saulnier, David R Langley, David B Frennesson, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2007
Respiratory syncytial virus fusion inhibitors. Part 5: Optimization of benzimidazole substitution patterns towards derivatives with improved activityXiangdong Alan Wang, Christopher W Cianci, Kuo-Long Yu, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2008
2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924Mark G Saulnier, David B Frennesson, Mark D Wittman, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|October 17, 2013
Genotypic correlates of susceptibility to HIV-1 attachment inhibitor BMS-626529, the active agent of the prodrug BMS-663068Nannan Zhou, Beata Nowicka-Sans, Brian McAuliffe, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|July 29, 2011
Cloning, purification, crystallization and preliminary X-ray analysis of the catalytic domain of human receptor-like protein tyrosine phosphatase γ in three different crystal formsKevin Kish, Patricia A McDonnell, Valentina Goldfarb, et al.
Nature Structural & Molecular Biology|January 4, 2024
Co-opting the E3 ligase KLHDC2 for targeted protein degradation by small moleculesChristopher M Hickey, Katherine M Digianantonio, Kurt Zimmermann, et al.
Bioorganic & Medicinal Chemistry Letters|December 24, 2018
Uncialamycin as a novel payload for antibody drug conjugate (ADC) based targeted cancer therapyNaidu S Chowdari, Chin Pan, Chetana Rao, et al.
Bioorganic & Medicinal Chemistry|February 6, 2014
Structure activity relationship studies of 3-arylsulfonyl-pyrido[1,2-a]pyrimidin-4-imines as potent 5-HT₆ antagonistsShuanghua Hu, Yazhong Huang, Yong-Jin Wu, et al.
Molecular Pharmacology|June 25, 2017
A Functional Na<sub>V</sub>1.7-Na<sub>V</sub>Ab Chimera with a Reconstituted High-Affinity ProTx-II Binding SiteRamkumar Rajamani, Sophie Wu, Iyoncy Rodrigo, et al.
Journal of Medicinal Chemistry|March 14, 2014
Discovery and development of hepatitis C virus NS5A replication complex inhibitorsMakonen Belema, Omar D Lopez, John A Bender, et al.
Organic Letters|March 25, 2005
Novel 3',6'-anhydro and N12,N13-bridged glycosylated fluoroindolo[2,3-a]carbazoles as topoisomerase I inhibitors. Fluorine as a leaving group from sp3 carbonMark G Saulnier, David R Langley, David B Frennesson, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2007
Respiratory syncytial virus fusion inhibitors. Part 5: Optimization of benzimidazole substitution patterns towards derivatives with improved activityXiangdong Alan Wang, Christopher W Cianci, Kuo-Long Yu, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2008
2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924Mark G Saulnier, David B Frennesson, Mark D Wittman, et al.
Pageof 6